Douglas D. Glover

1.4k total citations
27 papers, 1.1k citations indexed

About

Douglas D. Glover is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Microbiology. According to data from OpenAlex, Douglas D. Glover has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Microbiology. Recurrent topics in Douglas D. Glover's work include Pregnancy and Medication Impact (8 papers), Reproductive tract infections research (7 papers) and Glutathione Transferases and Polymorphisms (5 papers). Douglas D. Glover is often cited by papers focused on Pregnancy and Medication Impact (8 papers), Reproductive tract infections research (7 papers) and Glutathione Transferases and Polymorphisms (5 papers). Douglas D. Glover collaborates with scholars based in United States. Douglas D. Glover's co-authors include Timothy S. Tracy, Steve N. Caritis, Raman Venkataramanan, Mayur M. Amonkar, Bryan Larsen, K. H. Joseph, Liying Wang, Carl J. Malanga, Yon Rojanasakul and Mohamadi Sarkar and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, American Journal of Physiology-Endocrinology and Metabolism and Pharmaceutical Research.

In The Last Decade

Douglas D. Glover

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas D. Glover United States 14 412 252 161 156 151 27 1.1k
K. Fotherby United Kingdom 25 1.0k 2.5× 233 0.9× 65 0.4× 79 0.5× 167 1.1× 106 2.0k
DJ Morgan Australia 19 264 0.6× 141 0.6× 59 0.4× 95 0.6× 91 0.6× 39 1.5k
Robert DiCenzo United States 15 128 0.3× 182 0.7× 91 0.6× 48 0.3× 112 0.7× 25 941
Sam Salman Australia 20 712 1.7× 214 0.8× 109 0.7× 44 0.3× 190 1.3× 84 1.3k
Hugh Wiltshire United Kingdom 17 210 0.5× 507 2.0× 715 4.4× 94 0.6× 199 1.3× 31 1.7k
M.O. Pulkkinen Finland 25 1.0k 2.5× 311 1.2× 111 0.7× 334 2.1× 111 0.7× 106 2.4k
Madhu Page‐Sharp Australia 24 866 2.1× 264 1.0× 133 0.8× 42 0.3× 218 1.4× 73 1.6k
Irene Mackraj South Africa 22 100 0.2× 294 1.2× 41 0.3× 608 3.9× 74 0.5× 69 1.5k
DJ Back United Kingdom 24 313 0.8× 415 1.6× 354 2.2× 17 0.1× 586 3.9× 49 1.5k
D.J. Back United Kingdom 29 629 1.5× 475 1.9× 388 2.4× 23 0.1× 615 4.1× 80 2.2k

Countries citing papers authored by Douglas D. Glover

Since Specialization
Citations

This map shows the geographic impact of Douglas D. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas D. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas D. Glover more than expected).

Fields of papers citing papers by Douglas D. Glover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas D. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas D. Glover. The network helps show where Douglas D. Glover may publish in the future.

Co-authorship network of co-authors of Douglas D. Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas D. Glover. A scholar is included among the top collaborators of Douglas D. Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas D. Glover. Douglas D. Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolwankar, Dhanashri, Douglas D. Glover, Joseph A. Ware, & Timothy S. Tracy. (2005). EXPRESSION AND FUNCTION OF ABCB1 AND ABCG2 IN HUMAN PLACENTAL TISSUE. Drug Metabolism and Disposition. 33(4). 524–529. 64 indexed citations
2.
Tracy, Timothy S., Raman Venkataramanan, Douglas D. Glover, & Steve N. Caritis. (2005). Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. American Journal of Obstetrics and Gynecology. 192(2). 633–639. 305 indexed citations
3.
Glover, Douglas D., et al.. (2004). Medication use in a rural gynecologic population: Prescription, over-the-counter, and herbal medicines. American Journal of Obstetrics and Gynecology. 190(2). 351–357. 28 indexed citations
4.
Sarkar, Mohamadi, et al.. (2003). Expression and Cyclic Variability of CYP3A4 and CYP3A7 Isoforms in Human Endometrium and Cervix During the Menstrual Cycle. Drug Metabolism and Disposition. 31(1). 1–6. 55 indexed citations
5.
Glover, Douglas D. & Bryan Larsen. (2003). Relationship of Fungal Vaginitis Therapy to Prior Antibiotic Exposure. Infectious Diseases in Obstetrics and Gynecology. 11(3). 157–160. 21 indexed citations
6.
Glover, Douglas D., et al.. (2003). Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. American Journal of Obstetrics and Gynecology. 188(4). 1039–1045. 192 indexed citations
7.
Glover, Douglas D., et al.. (2001). Candidiasis During Pregnancy May Result From Isogenic Commensal Strains. Infectious Diseases in Obstetrics and Gynecology. 9(2). 65–73. 9 indexed citations
8.
Barnette, K. Gary, et al.. (1999). Glutathione S-Transferase in Human Endometrium: Quantitation and Interindividual Variability in Isoform Content. Gynecologic and Obstetric Investigation. 47(2). 114–119. 9 indexed citations
9.
Larsen, Bryan & Douglas D. Glover. (1998). Serum erythromycin levels in pregnancy. Clinical Therapeutics. 20(5). 971–977. 2 indexed citations
10.
Glover, Douglas D., et al.. (1998). Regiospecific expression of cytochrome P4501A1 and 1B1 in human uterine tissue. Cancer Letters. 122(1-2). 143–150. 41 indexed citations
11.
Korzekwa, Kenneth R., et al.. (1997). The effects of diabetes on placental aromatase activity. The Journal of Steroid Biochemistry and Molecular Biology. 63(1-3). 147–153. 11 indexed citations
12.
Glover, Douglas D., et al.. (1996). Regiospecificity of Placental Metabolism by Cytochromes P450 and Glutathione S-Transferase. Gynecologic and Obstetric Investigation. 42(3). 154–158. 14 indexed citations
13.
Glover, Douglas D., David Lalka, & Gilles R.G. Monif. (1996). Ampicillin vs. penicillin for in utero therapy. Infectious Diseases in Obstetrics and Gynecology. 4(1). 43–46. 7 indexed citations
14.
Glover, Douglas D., et al.. (1995). In situ Mycotoxin Production byCandidaalbicansin Women with Vaginitis. Gynecologic and Obstetric Investigation. 39(1). 67–69. 32 indexed citations
15.
Glover, Douglas D., David Lalka, & Gilles R.G. Monif. (1995). Ampicillin Vs. Penicillin for In Utero Therapy. Infectious Diseases in Obstetrics and Gynecology. 4(1). 43–46. 7 indexed citations
16.
Stanek, Ronald J., et al.. (1992). High performance ion exclusion chromatographic characterization of the vaginal organic acids in women with bacterial vaginosis. Biomedical Chromatography. 6(5). 231–235. 17 indexed citations
17.
Rojanasakul, Yon, et al.. (1992). The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit. Pharmaceutical Research. 9(8). 1029–1034. 173 indexed citations
18.
Glover, Douglas D., et al.. (1992). Chlamydia trachomatis antigen prevalence among pregnant women in West Virginia.. PubMed. 88(12). 548–51. 1 indexed citations
19.
Stanek, Ronald J., et al.. (1987). Evaluation of vaginal malodor and efficacy of treatment by high performance ion exchange chromatography. Biomedical Chromatography. 2(2). 76–78. 1 indexed citations
20.
Larsen, Bryan, et al.. (1986). Implications of Metronidazole Pharmacodynamics for Therapy of Trichomoniasis. Gynecologic and Obstetric Investigation. 21(1). 12–18. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026